(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADH1 mRNA] CTD PMID:31150632 1,2-dimethylhydrazine decreases expression ISO RGD:10090 6480464 1, 2-Dimethylhydrazine results in decreased expression of ADH1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:10090 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ADH1 mRNA CTD PMID:22206623 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine decreases expression EXP 6480464 chlorcyclizine results in decreased expression of ADH1 mRNA CTD PMID:21058326 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ADH1 mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression ISO RGD:10090 6480464 Ethinyl Estradiol results in increased expression of ADH1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of ADH1 mRNA CTD PMID:15953391 , PMID:17108234 17alpha-ethynylestradiol multiple interactions ISO RGD:10090 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADH1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:10090 6480464 Ethinyl Estradiol affects the expression of ADH1 mRNA CTD PMID:17555576 17beta-estradiol decreases expression ISO RGD:1344246 6480464 Estradiol results in decreased expression of ADH1C mRNA CTD PMID:20106945 17beta-estradiol increases expression ISO RGD:10090 6480464 Estradiol results in increased expression of ADH1 mRNA CTD PMID:14664709 1H-pyrazole multiple interactions ISO RGD:10090 6480464 pyrazole inhibits the reaction [ADH1 protein results in increased metabolism of Ethanol] CTD PMID:7646056 1H-pyrazole decreases activity EXP 6480464 pyrazole results in decreased activity of ADH1 protein CTD PMID:15551062 1H-pyrazole decreases activity ISO RGD:10090 6480464 pyrazole results in decreased activity of ADH1 protein CTD PMID:16289176 2,3,7,8-tetrabromodibenzodioxine decreases expression ISO RGD:10090 6480464 2 more ... CTD PMID:27604104 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10090 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADH1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ADH1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10090 6480464 Tetrachlorodibenzodioxin results in increased expression of ADH1 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADH1 mRNA CTD PMID:18796159 , PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1344246 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADH1C mRNA CTD PMID:20106945 , PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1344246 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ADH1C mRNA CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10090 6480464 Tetrachlorodibenzodioxin affects the expression of ADH1 mRNA CTD PMID:17949056 , PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1344246 6480464 Tetrachlorodibenzodioxin affects the expression of ADH1C mRNA CTD PMID:22298810 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ADH1 mRNA CTD PMID:21346803 2-butoxyethanol decreases expression ISO RGD:10090 6480464 n-butoxyethanol results in decreased expression of ADH1 mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:34256052 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 AHR gene mutant form inhibits the reaction [3 more ... CTD PMID:34256052 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1344246 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ADH1C mRNA CTD PMID:28628672 4'-hydroxyacetophenone affects binding EXP 1642947 p-hydroxyacetophenone binds to Adh1 protein RGD 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ADH1 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of ADH1 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol increases expression ISO RGD:10090 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ADH1 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:10090 6480464 Fenretinide results in increased expression of ADH1C mRNA CTD PMID:28973697 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole decreases expression ISO RGD:1344246 6480464 Omeprazole results in decreased expression of ADH1C mRNA CTD PMID:12040753 acetaldehyde increases chemical synthesis ISO RGD:10090 6480464 ADH1 protein results in increased chemical synthesis of Acetaldehyde CTD PMID:11893554 acetaldehyde multiple interactions ISO RGD:1344246 6480464 [ADH1C protein results in increased metabolism of Ethanol] which results in increased chemical synthesis of Acetaldehyde CTD PMID:15138216 acetaldehyde multiple interactions ISO RGD:10090 6480464 [ADH1 protein co-treated with Ethanol] results in increased abundance of Acetaldehyde more ... CTD PMID:11981770 , PMID:7646056 acetamide increases expression EXP 6480464 acetamide results in increased expression of ADH1 mRNA CTD PMID:31881176 acetone multiple interactions ISO RGD:10090 6480464 [ADH1 protein results in increased oxidation of allyl alcohol] which results in increased abundance of Acetone CTD PMID:11981770 acrolein affects reduction EXP 6480464 ADH1 protein affects the reduction of Acrolein CTD PMID:12604195 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of ADH1 mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:1344246 6480464 Aflatoxin B1 affects the expression of ADH1C protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:1344246 6480464 Aflatoxin B1 results in decreased expression of ADH1C mRNA CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1344246 6480464 Tretinoin results in increased expression of ADH1C mRNA CTD PMID:23830798 allyl alcohol increases oxidation ISO RGD:10090 6480464 ADH1 protein results in increased oxidation of allyl alcohol CTD PMID:11981770 allyl alcohol multiple interactions ISO RGD:10090 6480464 [ADH1 protein results in increased oxidation of allyl alcohol] which results in increased abundance of Acetone CTD PMID:11981770 alpha-hexachlorocyclohexane decreases expression EXP 6480464 alpha-hexachlorocyclohexane results in decreased expression of ADH1 mRNA CTD PMID:16940010 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ADH1 mRNA CTD PMID:18178546 atazanavir sulfate multiple interactions ISO RGD:1344246 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ADH1C mRNA CTD PMID:33819548 benzalkonium chloride decreases expression ISO RGD:10090 6480464 Benzalkonium Compounds results in decreased expression of ADH1 mRNA CTD PMID:31199489 benzene affects expression EXP 6480464 Benzene affects the expression of ADH1 mRNA CTD PMID:15878777 benzo[a]pyrene increases mutagenesis ISO RGD:1344246 6480464 Benzo(a)pyrene results in increased mutagenesis of ADH1C gene CTD PMID:25435355 benzo[a]pyrene decreases expression ISO RGD:1344246 6480464 Benzo(a)pyrene results in decreased expression of ADH1C mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1344246 6480464 Benzo(a)pyrene affects the methylation of ADH1C promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:10090 6480464 Benzo(a)pyrene results in increased expression of ADH1 mRNA CTD PMID:22228805 bifenthrin increases expression ISO RGD:10090 6480464 bifenthrin results in increased expression of ADH1 mRNA CTD PMID:26071804 bis(2-ethylhexyl) phthalate affects expression ISO RGD:10090 6480464 Diethylhexyl Phthalate affects the expression of ADH1 mRNA CTD PMID:27405655 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ADH1C mRNA CTD PMID:22842222 , PMID:25181051 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ADH1 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1344246 6480464 bisphenol A results in increased expression of ADH1C mRNA CTD PMID:29275510 bisphenol A increases expression ISO RGD:10090 6480464 bisphenol A results in increased expression of ADH1 mRNA CTD PMID:30790712 , PMID:30951980 bisphenol F increases expression ISO RGD:10090 6480464 bisphenol F results in increased expression of ADH1 mRNA CTD PMID:30951980 bosentan decreases expression ISO RGD:1344246 6480464 Bosentan results in decreased expression of ADH1C mRNA, Bosentan results in decreased expression of ADH1C protein CTD PMID:29761207 cadmium dichloride increases expression ISO RGD:10090 6480464 Cadmium Chloride results in increased expression of ADH1 mRNA CTD PMID:24982889 carbon nanotube decreases expression ISO RGD:10090 6480464 Nanotubes more ... CTD PMID:25554681 chenodeoxycholic acid multiple interactions ISO RGD:1344246 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ADH1C mRNA more ... CTD PMID:33819548 chlordecone increases expression ISO RGD:10090 6480464 Chlordecone results in increased expression of ADH1 mRNA CTD PMID:33711761 chlordecone decreases expression ISO RGD:10090 6480464 Chlordecone results in decreased expression of ADH1 mRNA CTD PMID:29980752 cimetidine multiple interactions ISO RGD:1344246 6480464 Cimetidine inhibits the reaction [ADH1C protein results in increased oxidation of Ethanol] CTD PMID:23220590 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of ADH1 protein CTD PMID:22023808 clofibrate multiple interactions ISO RGD:10090 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ADH1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ADH1 mRNA] CTD PMID:17585979 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of ADH1 mRNA CTD PMID:12851107 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ADH1 mRNA CTD PMID:17602206 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of ADH1 mRNA, cobaltous chloride results in increased expression of ADH1 protein CTD PMID:24386269 copper atom decreases expression EXP 6480464 Copper results in decreased expression of ADH1 mRNA CTD PMID:22465980 , PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ADH1 mRNA CTD PMID:22465980 , PMID:30556269 crotonaldehyde affects reduction EXP 6480464 ADH1 protein affects the reduction of 2-butenal CTD PMID:12604195 cyanamide multiple interactions ISO RGD:10090 6480464 Cyanamide promotes the reaction [[ADH1 protein co-treated with Ethanol] results in increased abundance of Acetaldehyde], Cyanamide promotes the reaction [[ADH1 protein results in increased metabolism of Ethanol] which results in increased chemical synthesis of Acetaldehyde] CTD PMID:11981770 , PMID:7646056 cyclosporin A decreases expression ISO RGD:1344246 6480464 Cyclosporine results in decreased expression of ADH1C mRNA CTD PMID:20106945 cyclosporin A multiple interactions ISO RGD:1344246 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of ADH1C mRNA CTD PMID:33819548 deoxycholic acid multiple interactions ISO RGD:1344246 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ADH1C mRNA more ... CTD PMID:33819548 dexamethasone increases expression ISO RGD:10090 6480464 Dexamethasone results in increased expression of ADH1 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:1344246 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ADH1C mRNA CTD PMID:28628672 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of ADH1 mRNA CTD PMID:20032058 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of ADH1 mRNA] CTD PMID:20032058 dexamethasone increases expression ISO RGD:1344246 6480464 Dexamethasone results in increased expression of ADH1C mRNA CTD PMID:25047013 dextran sulfate multiple interactions ISO RGD:10090 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADH1 mRNA CTD PMID:29950665 dibutyl phthalate multiple interactions ISO RGD:10090 6480464 [Dibutyl Phthalate results in increased abundance of monobutyl phthalate] which affects the expression of ADH1 mRNA CTD PMID:34175954 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of ADH1 protein CTD PMID:25772430 diethyl malate affects expression ISO RGD:10090 6480464 diethyl malate affects the expression of ADH1 mRNA CTD PMID:24814887 diethylstilbestrol decreases expression ISO RGD:10090 6480464 Diethylstilbestrol results in decreased expression of ADH1 mRNA CTD PMID:15171707 dioxygen decreases expression ISO RGD:1344246 6480464 Oxygen deficiency results in decreased expression of ADH1C mRNA CTD PMID:19695866 disulfiram decreases activity EXP 6480464 Disulfiram results in decreased activity of ADH1 protein CTD PMID:15551062 endosulfan multiple interactions ISO RGD:1344246 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ADH1C mRNA CTD PMID:26159488 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of ADH1 mRNA CTD PMID:29038839 ethanol multiple interactions ISO RGD:10090 6480464 [ADH1 protein co-treated with Ethanol] results in increased abundance of Acetaldehyde more ... CTD PMID:11981770 more ... ethanol decreases expression ISO RGD:10090 6480464 Ethanol results in decreased expression of ADH1 mRNA CTD PMID:28119953 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of ADH1C protein CTD PMID:23200777 ethanol increases oxidation ISO RGD:1344246 6480464 ADH1C protein results in increased oxidation of Ethanol CTD PMID:21167143 , PMID:23220590 ethanol increases expression ISO RGD:1344246 6480464 Ethanol results in increased expression of ADH1C mRNA CTD PMID:23300006 ethanol affects response to substance ISO RGD:1344246 6480464 ADH1C gene polymorphism affects the susceptibility to Ethanol CTD PMID:20171022 ethanol increases expression ISO RGD:10090 6480464 Ethanol results in increased expression of ADH1 mRNA, Ethanol results in increased expression of ADH1 protein CTD PMID:22554647 more ... ethanol increases metabolic processing ISO RGD:1344246 6480464 ADH1C protein results in increased metabolism of Ethanol CTD PMID:15138216 , PMID:19822198 ethanol increases metabolic processing ISO RGD:10090 6480464 ADH1 protein results in increased metabolism of Ethanol CTD PMID:7646056 , PMID:7943667 ethanol multiple interactions ISO RGD:1344246 6480464 [ADH1C protein results in increased metabolism of Ethanol] which results in increased chemical synthesis of Acetaldehyde more ... CTD PMID:15138216 more ... ethanol multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Ethanol results in increased expression of ADH1 mRNA] more ... CTD PMID:20705415 , PMID:25111957 ethanol increases expression EXP 6480464 Ethanol results in increased expression of ADH1 mRNA CTD PMID:15353170 , PMID:20705415 ethylene glycol increases oxidation ISO RGD:1344246 6480464 ADH1C protein results in increased oxidation of Ethylene Glycol CTD PMID:21167143 fenofibrate decreases expression ISO RGD:1344246 6480464 Fenofibrate results in decreased expression of ADH1C mRNA CTD PMID:25572481 fluconazole decreases expression EXP 6480464 Fluconazole results in decreased expression of ADH1 mRNA CTD PMID:16643972 fluoranthene multiple interactions ISO RGD:10090 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of ADH1 mRNA CTD PMID:28329830 folic acid multiple interactions ISO RGD:10090 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ADH1 mRNA CTD PMID:22206623 fomepizole decreases activity ISO RGD:10090 6480464 fomepizole results in decreased activity of ADH1 protein CTD PMID:7943667 fomepizole multiple interactions ISO RGD:1344246 6480464 fomepizole inhibits the reaction [ADH1C protein results in increased oxidation of Ethanol] CTD PMID:21167143 formaldehyde decreases response to substance EXP 6480464 ADH1 protein results in decreased susceptibility to Formaldehyde CTD PMID:21276436 glycochenodeoxycholic acid multiple interactions ISO RGD:1344246 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ADH1C mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO RGD:1344246 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ADH1C mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO RGD:1344246 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ADH1C mRNA more ... CTD PMID:33819548 hydrogen peroxide multiple interactions ISO RGD:10090 6480464 Hydrogen Peroxide results in decreased expression of and results in decreased activity of ADH1 protein CTD PMID:31870920 hydrogen peroxide increases expression ISO RGD:10090 6480464 Hydrogen Peroxide results in increased expression of ADH1 mRNA CTD PMID:31870920 indometacin multiple interactions ISO RGD:1344246 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ADH1C mRNA CTD PMID:28628672 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of ADH1 mRNA CTD PMID:20097248 isoprenaline increases expression ISO RGD:10090 6480464 Isoproterenol results in increased expression of ADH1 mRNA CTD PMID:20003209 methanol increases oxidation ISO RGD:1344246 6480464 ADH1C protein results in increased oxidation of Methanol CTD PMID:21167143 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of ADH1 mRNA CTD PMID:25972201 milrinone increases expression EXP 6480464 Milrinone results in increased expression of ADH1 mRNA CTD PMID:22936366 Monobutylphthalate multiple interactions ISO RGD:10090 6480464 [Dibutyl Phthalate results in increased abundance of monobutyl phthalate] which affects the expression of ADH1 mRNA CTD PMID:34175954 Muconic dialdehyde increases reduction ISO RGD:10090 6480464 ADH1 protein results in increased reduction of muconaldehyde CTD PMID:16289176 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Ethanol results in increased expression of ADH1 mRNA] CTD PMID:20705415 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ADH1 mRNA CTD PMID:17602206 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of ADH1 mRNA CTD PMID:25380136 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of ADH1 protein CTD PMID:19716841 naphthalene decreases expression EXP 6480464 naphthalene analog results in decreased expression of ADH1 mRNA CTD PMID:24976557 nefazodone multiple interactions ISO RGD:1344246 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ADH1C mRNA CTD PMID:33819548 nickel atom decreases expression ISO RGD:10090 6480464 Nickel results in decreased expression of ADH1 mRNA CTD PMID:12540486 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of ADH1 mRNA CTD PMID:33484710 obeticholic acid decreases expression ISO RGD:1344246 6480464 obeticholic acid results in decreased expression of ADH1C mRNA CTD PMID:27939613 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of ADH1 mRNA CTD PMID:12700408 oleanolic acid multiple interactions EXP 6480464 Oleanolic Acid inhibits the reaction [Ethanol results in increased expression of and results in increased activity of ADH1 protein] CTD PMID:25111957 omeprazole decreases expression ISO RGD:1344246 6480464 Omeprazole results in decreased expression of ADH1C mRNA CTD PMID:12040753 ouabain affects expression ISO RGD:1344246 6480464 Ouabain affects the expression of ADH1C protein CTD PMID:17268060 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of ADH1C mRNA CTD PMID:27638505 paracetamol multiple interactions ISO RGD:10090 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ADH1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ADH1 mRNA] CTD PMID:17585979 paracetamol multiple interactions ISO RGD:1344246 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ADH1C mRNA CTD PMID:33819548 paracetamol affects binding EXP 1642947 p-acetamidophenol binds to Adh1 protein RGD paracetamol decreases expression ISO RGD:1344246 6480464 Acetaminophen results in decreased expression of ADH1C mRNA CTD PMID:21420995 paracetamol affects expression ISO RGD:10090 6480464 Acetaminophen affects the expression of ADH1 mRNA CTD PMID:17562736 pentachlorophenol multiple interactions ISO RGD:1344246 6480464 Pentachlorophenol inhibits the reaction [ADH1C protein results in increased metabolism of Ethanol] CTD PMID:19822198 perfluorooctane-1-sulfonic acid affects expression ISO RGD:10090 6480464 perfluorooctane sulfonic acid affects the expression of ADH1 mRNA CTD PMID:19429403 perfluorooctanoic acid affects expression ISO RGD:10090 6480464 perfluorooctanoic acid affects the expression of ADH1 mRNA CTD PMID:19429403 perfluorooctanoic acid decreases expression ISO RGD:1344246 6480464 perfluorooctanoic acid results in decreased expression of ADH1C mRNA CTD PMID:27153767 pirinixic acid multiple interactions ISO RGD:10090 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ADH1 mRNA CTD PMID:19710929 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ADH1 mRNA CTD PMID:22112501 pirinixic acid increases expression ISO RGD:10090 6480464 pirinixic acid results in increased expression of ADH1 mRNA CTD PMID:17426115 , PMID:20813756 potassium dichromate affects expression ISO RGD:10090 6480464 Potassium Dichromate affects the expression of ADH1 mRNA CTD PMID:23608068 pravastatin decreases expression ISO RGD:10090 6480464 Pravastatin results in decreased expression of ADH1 mRNA CTD PMID:27225895 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of ADH1 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of ADH1 mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:10090 6480464 Pregnenolone Carbonitrile results in decreased expression of ADH1 mRNA CTD PMID:28903501 progesterone increases expression ISO RGD:1344246 6480464 Progesterone results in increased expression of ADH1C mRNA CTD PMID:20864642 propan-2-ol increases oxidation ISO RGD:10090 6480464 ADH1 protein results in increased oxidation of 2-Propanol CTD PMID:11981770 propan-2-ol increases oxidation ISO RGD:1344246 6480464 ADH1C protein results in increased oxidation of 2-Propanol CTD PMID:21167143 propanal decreases expression ISO RGD:1344246 6480464 propionaldehyde results in decreased expression of ADH1C mRNA CTD PMID:26079696 raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of ADH1 mRNA CTD PMID:15576828 rifampicin increases expression ISO RGD:1344246 6480464 Rifampin results in increased expression of ADH1C mRNA CTD PMID:12040753 rotenone decreases expression ISO RGD:1344246 6480464 Rotenone results in decreased expression of ADH1C mRNA CTD PMID:29955902 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 Buthionine Sulfoximine promotes the reaction [Ethanol results in increased expression of ADH1 mRNA] CTD PMID:20705415 silicon dioxide decreases expression ISO RGD:1344246 6480464 Silicon Dioxide analog results in decreased expression of ADH1C mRNA CTD PMID:25895662 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of ADH1 mRNA CTD PMID:32721576 sodium arsenite decreases expression ISO RGD:1344246 6480464 sodium arsenite results in decreased expression of ADH1C mRNA CTD PMID:29301061 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ADH1 protein CTD PMID:29459688 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of ADH1 mRNA CTD PMID:25905778 Sunset Yellow FCF multiple interactions ISO RGD:1344246 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ADH1C mRNA CTD PMID:33819548 tamoxifen affects expression ISO RGD:10090 6480464 Tamoxifen affects the expression of ADH1 mRNA CTD PMID:17555576 taraxerone multiple interactions ISO RGD:10090 6480464 taraxerone promotes the reaction [Ethanol results in increased expression of ADH1 mRNA] CTD PMID:22554647 tartrazine multiple interactions ISO RGD:1344246 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH1C mRNA CTD PMID:33819548 tauroursodeoxycholic acid decreases expression EXP 6480464 ursodoxicoltaurine results in decreased expression of ADH1 mRNA CTD PMID:15885361 testosterone decreases expression ISO RGD:10090 6480464 Testosterone results in decreased expression of ADH1 mRNA CTD PMID:19693291 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of ADH1 mRNA] CTD PMID:20032058 tetrachloroethene decreases expression ISO RGD:10090 6480464 Tetrachloroethylene results in decreased expression of ADH1 mRNA CTD PMID:28973375 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADH1 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:10090 6480464 Carbon Tetrachloride results in decreased expression of ADH1 mRNA CTD PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ADH1 mRNA CTD PMID:30723492 , PMID:31150632 tetrachloromethane multiple interactions ISO RGD:10090 6480464 Carbon Tetrachloride results in decreased expression of and results in decreased activity of ADH1 protein CTD PMID:31870920 titanium dioxide increases expression ISO RGD:10090 6480464 titanium dioxide results in increased expression of ADH1 mRNA CTD PMID:23131501 titanium dioxide multiple interactions ISO RGD:10090 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADH1 mRNA CTD PMID:29950665 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of ADH1 mRNA CTD PMID:16643972 trichloroethene affects expression ISO RGD:10090 6480464 Trichloroethylene affects the expression of ADH1 mRNA CTD PMID:29353386 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of ADH1 mRNA CTD PMID:33387578 trimellitic anhydride decreases expression ISO RGD:10090 6480464 trimellitic anhydride results in decreased expression of ADH1 mRNA CTD PMID:19042947 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of ADH1 mRNA CTD PMID:30589522 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of ADH1 mRNA CTD PMID:23639586 troglitazone decreases expression ISO RGD:1344246 6480464 troglitazone results in decreased expression of ADH1C mRNA CTD PMID:25572481 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of ADH1 mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:1344246 6480464 Valproic Acid results in decreased expression of ADH1C mRNA, Valproic Acid results in decreased expression of ADH1C protein CTD PMID:29154799 , PMID:29501571 valproic acid increases expression ISO RGD:10090 6480464 Valproic Acid results in increased expression of ADH1 mRNA CTD PMID:24896083 valproic acid affects expression ISO RGD:10090 6480464 Valproic Acid affects the expression of ADH1 mRNA CTD PMID:17292431 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of ADH1C mRNA CTD PMID:12672911 zinc atom multiple interactions ISO RGD:10090 6480464 [Zinc co-treated with Ethanol] results in increased expression of ADH1 mRNA CTD PMID:19637192 zinc sulfate multiple interactions ISO RGD:10090 6480464 [Ethanol co-treated with Zinc Sulfate] results in increased activity of ADH1 protein, [Ethanol co-treated with Zinc Sulfate] results in increased expression of ADH1 protein CTD PMID:15920153 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of ADH1C mRNA CTD PMID:12672911 zinc(0) multiple interactions ISO RGD:10090 6480464 [Zinc co-treated with Ethanol] results in increased expression of ADH1 mRNA CTD PMID:19637192
